ZNF74 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.887200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.162000E-01
Normal-vs-Stage2
2.419000E-01
Normal-vs-Stage3
6.296100E-02
Normal-vs-Stage4
5.984000E-01
Stage1-vs-Stage2
5.026600E-01
Stage1-vs-Stage3
6.445700E-02
Stage1-vs-Stage4
9.916600E-01
Stage2-vs-Stage3
1.900950E-01
Stage2-vs-Stage4
5.952600E-01
Stage3-vs-Stage4
2.445800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.011600E-01
Normal-vs-AfricanAmerican
6.021400E-01
Normal-vs-Asian
2.668200E-01
Caucasian-vs-AfricanAmerican
5.795200E-01
Caucasian-vs-Asian
9.492800E-01
AfricanAmerican-vs-Asian
6.098800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.634000E-01
Normal-vs-Female
3.373200E-01
Male-vs-Female
6.147000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.736400E-01
Normal-vs-Age(41-60Yrs)
3.248400E-01
Normal-vs-Age(61-80Yrs)
2.709800E-01
Normal-vs-Age(81-100Yrs)
4.098800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.896800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.670400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.776800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.443760E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.563000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.842800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.736160E-01
Normal-vs-Daily Drinker
1.361020E-01
Normal-vs-Weekly Drinker
9.700800E-01
Normal-vs-Occasional Drinker
5.527000E-01
Normal-vs-Social Drinker
4.665400E-01
Non Drinker-vs-Daily Drinker
6.622000E-01
Non Drinker-vs-Weekly Drinker
1.773610E-02
Non Drinker-vs-Occasional Drinker
1.656640E-01
Non Drinker-vs-Social Drinker
1.663380E-01
Daily Drinker-vs-Weekly Drinker
1.298060E-02
Daily Drinker-vs-Occasional Drinker
1.017570E-01
Daily Drinker-vs-Social Drinker
9.678400E-02
Weekly Drinker-vs-Occasional Drinker
3.059200E-01
Weekly Drinker-vs-Social Drinker
2.804000E-01
Occasional Drinker-vs-Social Drinker
9.873400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.799000E-01
Normal-vs-Grade 2
8.667600E-01
Normal-vs-Grade 3
8.522400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.773800E-01
Grade 1-vs-Grade 3
5.519400E-01
Grade 1-vs-Grade 4
8.799000E-01
Grade 2-vs-Grade 3
6.355200E-01
Grade 2-vs-Grade 4
8.667600E-01
Grade 3-vs-Grade 4
8.522400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.370400E-01
Normal-vs-NonDiabetic
3.066200E-01
Diabetic-vs-NonDiabetic
3.920200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.167800E-01
Normal-vs-NoPancreatitis
2.708000E-01
Pancreatitis-vs-NoPancreatitis
2.165800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.161400E-01
Normal-vs-N1
2.906800E-01
N0-vs-N1
9.701800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.942200E-01
Normal-vs-TP53-NonMutant
6.492400E-01
TP53-Mutant-vs-TP53-NonMutant
3.906200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
